Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Bruno Pradines
In Vitro Activity of Proveblue (Methylene Blue) on Plasmodium Falciparum Strains Resistant to Standard Antimalarial Drugs
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Absence of Association Between Polymorphisms in the RING E3 Ubiquitin Protein Ligase Gene andEx VivoSusceptibility to Conventional Antimalarial Drugs in Plasmodium Falciparum Isolates From Dakar, Senegal
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Role of Pfmdr1 in in Vitro Plasmodium Falciparum Susceptibility to Chloroquine, Quinine, Monodesethylamodiaquine, Mefloquine, Lumefantrine, and Dihydroartemisinin
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Baseline Ex Vivo and Molecular Responses of Plasmodium Faciparum Isolates to Piperaquine Before Implementation of Dihydroartemisinin-Piperaquine in Senegal
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Dose Responses of Proveblue Methylene Blue in an Experimental Murine Cerebral Malaria Model
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Impact of Methylene Blue and Atorvastatin Combination Therapy on the Apparition of Cerebral Malaria in a Murine Model
Malaria Journal
Parasitology
Infectious Diseases
Reduced in Vitro Susceptibility to Artemisinin Derivatives Associated With Multi-Resistance in a Traveller Returning From South-East Asia
Malaria Journal
Parasitology
Infectious Diseases
Prevalence of Plasmodium Falciparum Antimalarial Drug Resistance Genes in Southeastern Gabon From 2011 to 2014
Infection and Drug Resistance
Infectious Diseases
Pharmacology
In Vitro Activities of Benflumetol Against 158 Senegalese Isolates of Plasmodium Falciparum in Comparison With Those of Standard Antimalarial Drugs
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Atorvastatin as a Potential Antimalarial Drug: In Vitro Synergy in Combinational Therapy With Dihydroartemisinin
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
